(Reuters) -Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider Becton Dickinson in a stock-and-cash transaction valued at $17.5 ...
Lab equipment maker Waters Corp will buy a bioscience and diagnostics unit spun off from medtech provider Becton Dickinson in a stock-and-cash transaction valued at $17.5 billion, the companies said ...
Waters shares fall nearly 14%, Becton shares rise 0.6% Waters to take on debt for $4 billion cash distribution to Becton Waters shareholders will own 61% of new company, Becton 39% Becton Dickinson, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results